Interestingly, somatic gain-of-function mutations in MyD88 have been found in many hematological malignancies such as activated B cell type diffuse large B cell lymphoma (ABC-DLBCL). This evidence concerns the gene MYD88 and diffuse large B-cell lymphoma.